毛利 正博 もうり まさひろ 先生

来歴等

略歴

1982年 九州大学医学部 卒業
1982年 九州大学医学部 循環器内科 入局
1990年 ドイツ連邦共和国マックス・プランク研究所(Wolfgang Schaper 教授)
1992年 九州大学医学部 循環器内科
1995年 九州大学医学部 冠動脈疾患治療部 講師
2003年 九州厚生年金病院 健康診断部 部長
2008年 九州厚生年金病院 循環器科 部長
2014年 独立行政法人地域医療機能推進機構九州病院 循環器科 部長 (機構への移行により病院名変更)
2018年 九州病院 内科 診療部長

論文

• Kuga T, Mohri M, Egashira K, Hirakawa Y,Tagawa T, Shimokawa H, Takeshita (1997) Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme. J Am Coll Cardiol 30:108-112.

• Mohri M, Egashira K, Tagawa T, Kuga T, Tagawa H, Harasawa Y, Shimokawa H,Takeshita A (1997) Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure. Hypertension 30:50-56.

• Tagawa T, Mohri M, Tagawa H, Egashira K, Shimokawa H, Kuga T, Hirooka Y, Takeshita A (1997) Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans. J Cardiovasc Pharmacol 29:546-553.

• Kluge A, Zimmermann R, Weihrauch D, Mohri M, Sack S, Schaper J, Schaper W (1997) Coordinate expression of the insulin-like growth factor system after microembolisation in porcine heart. Cardiovasc Res 33:324-331.

• Mohri M, Egashira K, Kuga T, Shimokawa H, Takeshita A (1997) Correlations between recruitable coronary collateral flow velocities, distal occlusion pressure, and electrocardiographic changes in patients undergoing angioplasty. Jpn Circ J 61:971-978.

• Mohri M, Koyanagi M, Egashira K, Tagawa H, Ichiki T, Shimokawa H, Takeshita A (1998) Angina pectoris caused by coronary microvascular spasm. Lancet 351:1165-1169.

• Arras M, Strasser R, Mohri M, Doll R, Eckert P, Schaper W, Schaper J. (1998) Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol 93:97-107

• Schwarz ER, Fleischhauer J, Montino H, Chakupurakal R, Foresti M, Schuetz T, Sack S, Mohri M, Arras M, Schaper W, Hanrath P (1998) Infarct size reduction by ischemic preconditioning is a monophasic, short-lived phenomenon in anesthetized pigs. J Cardiovasc Pharmacol Ther 3:63-70.

• Mohri M, Tagawa H, Egashira K, Takeshita A (2000) Intracoronary enalaprilat improves metabolic coronary vasodilation in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 35:249-255

• Sasazuki S, Kodama H, Yoshimasu K, Liu Y, Washio M, Tanaka K, Tokunaga S,Kono S, Arai H, Doi Y, Kawano T, Nakagaki 0, Takada K, Koyanagi S, Hiyamuta K, Nii T, Shirai K, Ideishi M, Arakawa K, Mohri M, Takeshita A (2000) Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese Men and Women. Ann Epidemiol 10:401-408

• Yoshimasu K, Liu Y, Kodama H, Sasazuki S, Washio M, Tanaka K, Tokunaga S,Kono S, Arai H, Koyanagi S, Hiyamuta K, Doi Y, Kawano T, Nakagaki 0, Takada K, Nii T, Shirai K, Ideishi M, Arakawa K, Mohri M, Takeshita A (2000) Job strain, type A behavior pattern, and the prevalence of coronary atherosclerosis in Japanese working men. J Psych Res 49:77-83

• Tanaka K, Kodama H, Sasazuki S, Yoshimasu K, Liu Y, Washio M, Tokunaga S,Kono S, Arai H, Koyanai S, Hiyamuta K, Doi Y, Kawano T, Nakagaki 0, Takada K, Nii T, Shirai K, Ideishi M, Arakawa K, Mohri M, Takeshita A (2001) Obesity, body fat distribution and coronary atherosclerosis among Japanese men and women. Int J Obesity 25:191-197.

• Setoguchi S, Mohri M, Shimokawa H, Takeshita A (2001) Tetrahydrobiopterinimproves endothelial dysfunction in the coronary microcirculation in patients without epicardial coronary artery disease. J Am Coll Cardiol 38:493-498

• Washio M, Sasazuki S, Kodama H, Yoshimasu K, Liu Y, Tanaka K, Tokunaga S, Kono S, Arai H, Koyanagi S, Hiyamuta K, Doi Y, Kawano T, Nakagaki O, Takada K, Nii T, Shirai K, Ideishi M, Arakawa K, Mohri M, Takeshita A (2001) Role of hypertension, dyslipidemia and diabetes mellitus in the development of coronary atherosclerosis in Japan.Jpn Circ J 65:731-737

• Masumoto A, Mohri M, Takeshita A (2001) Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm.Int J Cardiol 81:151-156

• Liu Y,Tanaka H,Sasazaki S,Yoshimatsu K,Kodama H,Washio M,Tanaka K,Tokunaga S, Kono S, Arai H, Koyanagi S, Hiyamuta K, Doi Y, Kawano T, Nakagaki 0, Takada K, Nii T, Shirai K, Ideishi M, Arakawa K, Mohri M, Takeshita A (2001) Alcohol consumption and severity of angiographically determined coronary artery disease in Japanese men and women. Atherosclerosis 156:177-183

• Mohri M, Ichiki T, Hirooka Y, Takeshita A (2002) Endogenous nitric oxide prevents myocardial ischemia in patients with hypertension and left ventricular hypertrophy. Am Heart J 143:684-689

• Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A (2002) Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 105:1545-1547

• Sun H, Mohri M, Shimokawa H, Usui M, Urakami L, Takeshita A (2002) Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol 39:847-851

• Mohri M, Shimokawa H, Hirakawa Y, Masumoto A, Takeshita A (2003) Rho-kinase inhibition with intracoronary fasudil ameliorates myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol 41:15-19

• Mohri M, Ichiki T, Kuga T, Takeshita A (2003) Evidence for anti-ischemic effect of dual-chamber pacing in patients with the obstructive form of hypertrophic cardiomyopathy. Jpn Heart J 44:587-92

• Inoue T, Mohri M, Fukumoto Y ,Inokuchi K, Takeshita A (2003) Wandering ST-segment elevation. Circulation 108:e102-3

• Mohri M (2003) Primary and secondary prevention of coronary artery disease. Fukuoka Acta Med 94:43-47

• Takemoto M, Yoshimura H, Ohba Y, Matsumoto Y, Yamamoto U, Mohri M, Yamamoto H, Origuchi H (2005) Radiofrequency catheter ablation of premature ventricular complexes from right ventricular outflow tract improves left ventricular dilatation and clinical status in patients without structural heart disease. J Am Coll Cardiol 45:1259-65

• Nagata T, Hyakuna Y, Miyata K, Mohri M.Contemporary pactice and outcomes of an elderly cohort of Japanese patients with non-ST-elevation acute coronary syndrome in the era of routine early invasive strategy.Int J Cardiol 2017;240:49-54.

• Abe K, Mohri M, et al. (2006) Chest pain and intimal flap detected by chest CT scan. Circulation 114;e64

• Fukumoto Y, Mohri M, Inokuchi K, Ito A, Hirakawa Y, Masumoto A, Hirooka Y, Takeshita A, Shimokawa H (2007) Anti-ischemic Effects of Fasudil, a Specific Rho-Kinase Inhibitor, in Patients With Stable Effort Angina. J Cardiovasc Pharmacol. 49:117-21.

• Yamamoto U, Mohri M, Shimada K, Origuchi H, Miyata K, Ito K, Abe K, Yamamoto H (2007) Six-Month aerobic exercise training ameliorates central sleep apnea in patients with chronic heart failure. J Card Fail 13;825-829

• Yamamoto H, Iwade T, Nakano R, Mohri M, Amari Y , Noma M (2007) Numerous small vegetations revealing Libman-Sacks endocarditis in catastrophic antiphospholipid syndrome Circulation 116;e531-e535

• 小川久雄ら（日本循環器学会ほか合同研究班）(2009) 冠攣縮性狭心症の診断と治療に関するガイドランCirc J 72 (suppl IV): 1195-1252

• Sakamoto I, Mohri M, Yamamoto H (2009) Rapid progression of coronary atherosclerosis by coronary artery spasm leading to acute coronary syndrome Circulation 2009;119:2233-4

• Urata M, Dokura J, Noma M, Mohri M (2009) A murmur of a tumor. Circulation 2009;120:e77-e78